A body of evidence suggests that depression is associated with chronic low-grade inflammation, and increased inflammatory cytokine levels including tumour necrosis factor, interleukin-1β and interleukin-6 (Moylan et al., 2013; Miller and Raison, 2016; Kohler et al., 2017). This evidence concerns the gene IL6 and depressive symptom measurement.